Navigation Links
Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHD
Date:4/18/2013

tion use as well as the possible side effects of these drug therapies." 

"The results of this study are eagerly awaited by the treatment community, especially by pediatricians, child psychologists and child psychiatrists who not only see severe side effects from current drug therapies but also worry about the significant risks for diversion and abuse of these drugs," said Ian Cook , M.D., Director of the UCLA Depression Research & Clinic Program, where initial studies of eTNS began in psychiatric conditions. Dr. Cook is also one of the inventors of eTNS and a Senior Scientific Advisor to NeuroSigma.

Background - TNS
The trigeminal nerve is the largest cranial nerve, offering a high-bandwidth pathway for signals to enter the brain.  The trigeminal nerve projects to specific areas of the brain, such as the locus coeruleus, nucleus tractus solitarius, thalamus and the cerebral cortex, which are involved in epilepsy, depression, PTSD, ADHD and other disorders. 

Trigeminal Nerve Stimulation (TNS) is the electrical stimulation of branches of the trigeminal nerve, which are located very close to the surface of the skin in the forehead.  The low-energy stimulus is confined to the soft tissues of the forehead without direct penetration into the brain.  PET imaging studies in humans confirm that eTNS activates or inhibits key regions implicated in these disorders and the changes were observed within minutes of therapy.

NeuroSigma is the exclusive worldwide licensee of UCLA's entire TNS intellectual property portfolio and continues to develop additional technologies and target additional indications.

CAUTION: In the United States, both eTNS™ and sTNS™ are investigational devices and are limited by Federal (or United States) law to investigational use.

eTNS, sTNS, Monarch, and the Monarch e
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
2. Quest Diagnostics Reports First Quarter 2013 Financial Results
3. Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results
4. Span-America Medical Systems To Release Second Quarter Results On May 1, 2013
5. Mindray to Report First Quarter 2013 Financial Results on May 6, 2013
6. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
7. Synthetic Biologics Reports Year End 2012 Financial Results
8. CareFusion to Report Third Quarter Fiscal 2013 Results on May 9
9. Questcor to Report First Quarter Results on April 30, 2013
10. Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
11. Cardinal Health To Release Third-Quarter Results For Fiscal Year 2013 On May 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
(Date:1/23/2015)... January 23, 2015 Heptares Therapeutics, the clinical-stage ... announce that the Malcolm Campbell Memorial Prize for ... President of Chemistry), Fiona Marshall (Chief Scientific Officer ... and co-founder) for the seminal contributions to GPCR drug discovery ...
(Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... 2011 Zimmer Holdings, Inc. (NYSE: ZMH ; ... earnings conference call will be broadcast live over the Internet ...  A news release detailing the quarterly results will be made ... conference call. The live audio webcast can ...
... 2011 Lanx ® , Inc., a privately held ... devices for spinal surgery, today announced the launch of ... American Association of Neurological Surgeons (AANS) Annual Meeting, Denver, ... minimally invasive fixation alternative to pedicle screws, intended to ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2Lanx®, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion 2
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative ... design to treat specific body parts and muscle groups. , ... easy to use patented cold therapy machine with the innovative ... and muscle injuries. IsoComforter has become the industry leader ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... , WEDNESDAY, July 13 (HealthDay News) -- People ... but virtual reality- and physical reality-based therapies may provide ... research suggests. In conducting the study, scheduled for ... of Physical Medicine and Rehabilitation , researchers assigned tasks ...
... development assistance from the Georgia Tech Research Institute (GTRI) ... an Atlanta-based company is developing what it hopes will ... hundreds of millions of people who wear glasses or ... To be used by optometrists and ophthalmologists, the ...
... News) -- For patients taking the heart rhythm drug amiodarone ... incidents of thyroid dysfunction than the brand-name medication, researchers report. ... difference between the two drugs, according to the report released ... . Amiodarone, a drug used to control arrhythmia -- ...
... from two major HIV prevention trials announced favorable results of ... of these trials, the Partners PrEP Study, has provided the ... both studies will need to be fully evaluated before it ... major trial that is ongoing. Investigators for VOICE Vaginal ...
... , WEDNESDAY, July 13 (HealthDay News) -- A ... fight the H1N1 epidemic in 2009 may not have boosted ... all. Guillain-Barre is a rare disorder, which causes a ... weakness and even paralysis. In 1976, a vaccine used ...
... (OA) is a leading cause of disability in the ... to raise awareness and increase knowledge of OA among ... American Journal of Nursing and the National Association of ... in the Prevention and Management of Osteoarthritis" on Thursday, ...
Cached Medicine News:Health News:'Virtual Reality' May Help in Parkinson's Therapy 2Health News:R&D collaboration focuses on new system for measuring and improving human vision 2Health News:R&D collaboration focuses on new system for measuring and improving human vision 3Health News:R&D collaboration focuses on new system for measuring and improving human vision 4Health News:Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid 2Health News:VOICE study will continue as it considers what action to take after results of 2 trials 2Health News:VOICE study will continue as it considers what action to take after results of 2 trials 3Health News:VOICE study will continue as it considers what action to take after results of 2 trials 4Health News:'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges 2Health News:State of the Science in the Prevention and Management of Osteoarthritis-A Conference for Nurses 2
... High performance Tecoflex stents that save inventory, ... Stents accommodate ureteral lengths from 22 cm ... allows the Quadra-Coil to glide over any ... These stents provide ease of placement and ...
... drainage from the ureteropelvic junction to the ... ease of placement and patient compliance. The ... repositioning and ease of removal. AQ® is ... when activated, attracts and holds water and ...
The CMV IgM enzyme immunoassay is for the qualitative detection of antibodies to cytomegalovirus. The CMV IgM assay is primarily indicated for the detection of early or recent infection....
The Shandon Sequenza uses the Shandon Coverplate system which ensures consistency and excellent staining quality. , , ,Allows the user to perform large immunostaining runs (up to 50 slides/run...
Medicine Products: